Literature DB >> 12625943

Inflammation and free radicals in tumor development and progression.

Futoshi Okada1.   

Abstract

Inflammation is thought to be one of the major contributors to carcinogenesis. Accumulated studies in this field revealed that free radicals produced by inflammatory cells not only cause direct damage to DNA but also exert indirect effects such as de-regulation of cell proliferation and apoptosis, stimulation of angiogenesis, and modification of gene/protein expressions and protein activities, all of which are a critical step toward carcinogenesis. Free radicals have also been reported to act as both initiator and promoter of carcinogenic process. Recent evidence shows that free radicals convert benign tumors to more malignant ones (i.e. tumor progression) leading to the final stage of carcinogenesis. This article reviews the current findings linking inflammation and cancer, and shed light on inflammatory cell-derived free radicals as major endogenous reactive substances for tumor development and progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12625943     DOI: 10.1179/135100002125001135

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  10 in total

1.  Sodium channel γENaC mediates IL-17 synergized high salt induced inflammatory stress in breast cancer cells.

Authors:  Suneetha Amara; Michael T Ivy; Elbert L Myles; Venkataswarup Tiriveedhi
Journal:  Cell Immunol       Date:  2015-12-19       Impact factor: 4.868

Review 2.  Functional foods and their role in cancer prevention and health promotion: a comprehensive review.

Authors:  Mohammad Aghajanpour; Mohamad Reza Nazer; Zia Obeidavi; Mohsen Akbari; Parya Ezati; Nasroallah Moradi Kor
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

Review 3.  Inflammation-related carcinogenesis: current findings in epidemiological trends, causes and mechanisms.

Authors:  Futoshi Okada
Journal:  Yonago Acta Med       Date:  2014-07-30       Impact factor: 1.641

4.  Evaluation of comparative and combined antimutagenic potential of vitamin C and vitamin E using histidine mutant Salmonella typhimurium strains.

Authors:  T A Ajith; Marry Ann; Joe Thomas
Journal:  Indian J Clin Biochem       Date:  2008-03-06

5.  Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase.

Authors:  F Okada; H Shionoya; M Kobayashi; T Kobayashi; H Tazawa; K Onuma; Y Iuchi; N Matsubara; T Ijichi; B Dugas; M Hosokawa
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

Review 6.  Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2015-05-29

Review 7.  Cancer stem cells as key drivers of tumour progression.

Authors:  Ain Zubaidah Ayob; Thamil Selvee Ramasamy
Journal:  J Biomed Sci       Date:  2018-03-06       Impact factor: 8.410

8.  Squamous cell carcinoma around a subperiosteal implant in the maxilla and the association of chronic mechanical irritation and peri-implantitis: a case report.

Authors:  Takuma Watanabe; Dai Kawahara; Ryo Inoue; Tomoki Kato; Noboru Ishihara; Hidemichi Kamiya; Kazuhisa Bessho
Journal:  Int J Implant Dent       Date:  2022-03-02

Review 9.  Squamous cell carcinoma and dental implants: A systematic review of case reports.

Authors:  S Jeelani; E Rajkumar; G Geena Mary; Parvez Ahmad Khan; Harish Gopal; Soumya Roy; T Maheswaran; B Anand
Journal:  J Pharm Bioallied Sci       Date:  2015-08

10.  Establishment and Validation of Nomogram Based on Combination of Pretreatment C-Reactive Protein/Albumin Ratio-EBV DNA Grade in Nasopharyngeal Carcinoma Patients Who Received Concurrent Chemoradiotherapy.

Authors:  Zhang-Zan Huang; Wen Wen; Xin Hua; Chen-Ge Song; Xi-Wen Bi; Jia-Jia Huang; Wen Xia; Zhong-Yu Yuan
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.